Precision Biosciences

Precision BioSciences uses its ARCUS genome editing platform to develop therapies for human diseases and food and agricultural solutions.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2019
Stage of Initial Investment
Series A
Initial Investment Year
2015